Paramyxoviridae infectious disease
MONDO:0005896Infections with viruses of the family paramyxoviridae. This includes morbillivirus infections; respirovirus infections; pneumovirus infections; henipavirus infections; avulavirus infections; and rubulavirus infections.
Also known as: Paramyxoviridae caused disease or disorder, Paramyxoviridae disease or disorder
53 clinical trials for this condition and its sub-types.
Follow this condition — get notified about new trialsSub-types
Broader categories
-
One shot, three viruses? new vaccine trial targets RSV, hMPV, and PIV3 in seniors
⭐️ VACCINE ⭐️ CompletedThis Phase 1 study tests a new vaccine that aims to protect against three respiratory viruses at once: RSV, hMPV, and PIV3. The trial involves 390 adults aged 60 and older and will check if the vaccine is safe and helps the body produce antibodies. Different combinations and dose…
Phase: PHASE1 • Sponsor: Sanofi Pasteur, a Sanofi Company • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 27, 2026 12:23 UTC
-
Nasal spray vaccine aims to protect kids from two breathing viruses
⭐️ VACCINE ⭐️ CompletedThis study tested two experimental nasal spray vaccines in 24 children aged 2 to 5 years. The vaccines target two viruses that can cause breathing problems: human metapneumovirus (HMPV) and parainfluenza virus type 3 (HPIV3). The main goal was to see if the vaccines are safe and …
Phase: PHASE1 • Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 27, 2026 12:07 UTC
-
Can toddlers get three vaccines at once? new study says yes
⭐️ VACCINE ⭐️ CompletedThis study tested whether giving a booster polio vaccine (sIPV) at the same time as MMR and hepatitis A vaccines is safe and works well in toddlers. About 889 healthy children aged 18 to 22 months who had already received their first polio and MMR shots took part. Researchers che…
Phase: PHASE4 • Sponsor: Sinovac Biotech Co., Ltd • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 27, 2026 08:11 UTC
-
New combo vaccine targets flu, RSV, and more in early trial
⭐️ VACCINE ⭐️ CompletedThis early-stage study tested the safety and immune response of new vaccines that combine protection against flu, RSV, hMPV, and PIV3 in healthy adults aged 18 to 49. Participants received a single shot of one of several vaccine formulas. The goal was to see if these combination …
Phase: PHASE1 • Sponsor: Sanofi • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 27, 2026 08:11 UTC
-
New MMR vaccine shows promise in protecting infants
⭐️ VACCINE ⭐️ CompletedThis study tested a new measles, mumps, and rubella (MMR) vaccine made by Shanghai Institute of Biological Products in 1,200 healthy children aged 9-11 months. The goal was to see if it works as well as the licensed GSK MMR vaccine and is safe. Children received one dose, and res…
Phase: PHASE3 • Sponsor: Shanghai Institute Of Biological Products • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 27, 2026 08:09 UTC
-
First mRNA vaccine against deadly nipah virus shows promise in early trial
⭐️ VACCINE ⭐️ CompletedThis early-stage trial tested an experimental mRNA vaccine (mRNA-1215) for Nipah virus, a deadly infection with no approved treatments. Forty healthy adults received two doses of the vaccine and were monitored for safety and immune response. The vaccine cannot cause Nipah infecti…
Phase: PHASE1 • Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 27, 2026 07:55 UTC
-
Rural patients get Hospital-Level care at home in landmark trial
Disease control CompletedThis study looked at whether giving hospital-level care to acutely ill adults in their own homes in rural areas works well. 160 people with various conditions like infections, heart failure, or COPD took part. The goal was to see if this approach could lower costs and help patien…
Phase: NA • Sponsor: Brigham and Women's Hospital • Aim: Disease control
Last updated Jun 27, 2026 07:57 UTC
-
New rapid test for infection and inflammation put to the test
Diagnosis CompletedThis study looked at how well a new, quick finger-prick test (LumiraDx CRP) measures CRP levels compared to a standard lab test. CRP is a marker of infection, inflammation, or tissue injury. 79 adults with symptoms of these conditions took part. The goal was to see if the new tes…
Sponsor: LumiraDx UK Limited • Aim: Diagnosis
Last updated Jun 27, 2026 13:07 UTC
-
New PET scan technique aims to sniff out hidden infections
Diagnosis CompletedThis early study tested whether a special PET scan using a radioactive form of vitamin B9 (11C-PABA) can help doctors see infections deep inside the body. Researchers scanned 13 healthy people and patients with known or suspected infections. The goal was to see if this method can…
Sponsor: Johns Hopkins University • Aim: Diagnosis
Last updated Jun 27, 2026 08:03 UTC
-
Free nutrition packs tied to measles shots in nigeria trial
Prevention CompletedThis study tested whether giving monthly nutritional supplements (SQ-LNS) to children aged 6-23 months could increase measles vaccination rates in northern Nigeria. Over 3,800 children participated across 20 wards. The goal was to see if the supplement acted as an incentive for f…
Phase: NA • Sponsor: Alliance for International Medical Action • Aim: Prevention
Last updated Jun 27, 2026 11:00 UTC
-
Measles wipes immune memory: study reveals hidden danger
Knowledge-focused CompletedThis completed study looked at how measles infection affects children's existing immunity and their ability to respond to vaccines. Researchers enrolled 264 children aged 1-15 in African regions, comparing those with acute measles to healthy controls. Participants received rabies…
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:31 UTC
-
Breastfeeding after MMR shot: is it safe for baby?
Knowledge-focused CompletedThis study looked at whether the measles vaccine virus can be found in the breast milk of new mothers who received the MMR vaccine shortly after giving birth. Fourteen breastfeeding women with no immunity to measles or rubella provided milk samples over two weeks. The goal was to…
Phase: PHASE4 • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:02 UTC
-
New study probes measles vaccine doubts among new york parents
Knowledge-focused CompletedThis study surveyed 99 caregivers of young children in a New York emergency department to find out why some are hesitant about the measles vaccine. Researchers also tested whether a simple message from a doctor could change their minds. The goal is to identify barriers and improv…
Sponsor: Albany Medical College • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:00 UTC
-
ICU antibiotic dosing: what really matters?
Knowledge-focused CompletedThis study looked at 156 critically ill patients to find out what factors help achieve the right levels of beta-lactam antibiotics in the blood. Researchers collected clinical data and used therapeutic drug monitoring to see which patients reached target concentrations. The goal …
Sponsor: Centre Hospitalier Universitaire de Nīmes • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:01 UTC